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The Effects of Mitochondrial Catalase Overexpression
on Alcohol-Induced Skeletal Toxicity
Kyler Pisciotta, Bretton Urban, Alexandra Denys, Kim Pedersen, Martin Ronis
LSUHSC, Chronic Alcohol Research Center

Introduction

Femoral Shaft QRT-PCR

Weight and Serum Analysis

• According to a 2019 survey by the NIAAA, 69.5% of
individuals over the age of 18 had consumed alcohol
(ethanol) in the past year, and 25.8% reported engaging in
binge drinking within the past month.
• Alcohol downregulates osteoblastogenesis and upregulates
osteoclastogenesis and adipogenesis within the skeleton
(1).

*
##

**

• Increased concentrations of reactive oxygen species
(ROS), including ROS generated by mitochondrial
metabolism, are hypothesized to be a mechanism by which
alcohol affects bone homeostasis, as suggested by the
protective effects of the dietary antioxidant Nacetylcysteine (NAC) (3).

*

Genotype X Treatment interaction P = 0.046
Figure 3: The weight change of each mouse was recorded as the difference between the weight of the first and
fourth days of the binge model. Ethanol-treated mice lose more weight than mice gavaged with PBS, but MCAT
mice have less weight loss than WT mice. Serum ELISA analysis to determine the concentration of procollagen
1a1 in circulation showed that mCAT overexpression is protective against the characteristic depletion of
procollagen 1a1. *, **: P < 0.05, 0.01 vs PBS. ##: P < 0.01 vs. WT.

• Overexpression of the hydrogen peroxide-removing
enzyme catalase in mitochondria reduces the effects of
aging on the skeleton (4).

Hypothesis
Overexpression of catalase in mitochondria
counteracts ethanol-mediated skeletal toxicity.

Conclusion and Discussion
Figure 1: QRT-PCR analysis of the femural shaft demonstrates that increased concentrations of mitochondrial catalase
did not result in protection from alcohol’s down regulation of expression of osteoblast markers (Smpd3 and Col1a1) or
upregulation of osteoclastogenesis markers (Calcr and RANKL). β-actin was used as a house-keeping gene. QRT-PCR
confirmed expression of human catalase only in MCAT mice (data not shown) and the overexpression of total amount
of catalase mRNA. **, ***: P < 0.01, 0.001 vs. PBS. #, ##: P < 0.05, 0.01 vs. WT.

Femoral Marrow QRT-PCR

• Overexpression of mitochondrial catalase protected against
ethanol-mediated downregulation of a serum bone formation
marker procollagen 1a1.
•

Overexpression of mitochondrial catalase protected against
systemic weight loss during gavage.

•

Unexpectedly, overexpression of mitochondrial catalase did not
prevent ethanol-mediated downregulation of gene expression for
Col1a1 and Smpd3 or ethanol-mediated upregulation of gene
expression for Calcr in femoral bone.

•

The 4-day ethanol gavage exposure did not upregulate
adipogenesis genes in bone marrow.

•

Further experiments with more animals are needed, as the small
numbers within the groups limit statistical impact (n= 3,4,4,4).

•

Further investigation into post translational effects that may
mediate alcohol effects on matrix protein secretion in bone are
needed.

•

Redox status of the cell may be another hypothesis to investigate
with regard to the mechanism of ethanol skeletal toxicity since
NAC is both a ROS scavenger and a glutathione precursor and
GSH/GSSG ratios have previously been suggested to impact
osteoblastogenesis (6).

Methods
• MCAT mice contain a transgene for human catalase fused to
the leader sequence of ornithine transcarbamylase targeting
the protein to mitochondria.
• Gavage Model: WT and MCAT mice were taken through a 4day gavage protocol with either PBS or 31.5% EtOH at
concentrations of 3, 3, 4, and 4.5 g/kg bodyweight. First and
fourth day weights were used to calculate weight change
throughout the protocol (5).
• RNA was isolated from femoral shafts and femoral bone
marrow. Concentrations were determined by absorbance at
260 nm. RNA quality was determined by Agilent RNA
Screentape System.
• QRT-PCR analysis determined the effects on gene expression
for markers of osteoblastogenesis (Col1a1, Smpd3),
osteoclastogenesis (Calcr, RANKL), and adipogenesis (Fabp2,
Ppar-γ, and Ebf-1). QRT-PCR also confirmed that human
mCAT transgene was properly overexpressed in mCAT mice
and not present in controls (5).
• Serum concentration of procollagen 1a1 was determined by
ELISA (5).

##

Figure 2: QRT-PCR analysis of femur bone marrow demonstrates that binge ethanol and overexpression of mCAT did
not have an effect on the expression of adipogenic markers (Fabp2, Ppar-γ, and Ebf-1). The house-keeping gene β-actin
was slightly downregulated in both WT and MCAT mice. Ethanol-mediated downregulation of Col1a1 expression was
not prevented in MCAT mice. *, **; P < 0.05. 0.01 vs. PBS.
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